VistaGen Therapeutics, Inc.
Q1 2024 13F Holders
Symbol
VTGN
CUSIP
92840H400
Type
Equity
Class
COM
Num filings
49
Total reported value, excl. options
$76.9 M
Compare 2024 Q1 to
2026 Q3
2026 Q2
2026 Q1
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q3
2024 Q2
2023 Q4
2023 Q3
2023 Q2
Manager
Report Date
Value ($000)
Shares
Option Type